All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
The Canadian Research and Development Pharmaceutical Sector, 2021
…economy in 2021. It builds on the annual reports produced since 2018, sponsored by Innovative Medicines Canada (IMC), an industry association representing patented medicine enterprises in Canada’s R&D pharmaceutical sector….
Clinical Trials Research Note
In many areas of high unmet patient need, early access to new medicines through clinical trials are the only option for Canadian patients. There are over 3,000 ongoing clinical trials…
Two years is too long – Understanding Canada’s Drug Access Pathway
Canadians wait two years for access to new medicines through our public drug plans. That’s a full year longer than patients in most other peer countries. Two years can feel…